| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3c192f248d645119f1ba5c9d893ecef4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c954a9957f71cf7e1f205ec072b06c51 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-326
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S514-824
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-736 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-736
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-105 |
| filingDate |
2017-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76164c31479ab4d727c8469ebdd495e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91527e5d648999af50bda4c68a98b28f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_abe1271b61a11598f20b3c47284a0339
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9d588e0b510ac7c8d39689f53e4dc6e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07150395655309c8dc5d78a3bf50f0ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd16a3d98897ab019d7b93c3fc9b4e25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ff942cfb2f3dd6e50cc2d5cecb25a49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12b9299108074e389dfaa3451bdafbe7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_750cc9c9a8601b3ae4e30991d29f7e56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_015d9dbff4b6ebb5a17ee812ac5f76d8 |
| publicationDate |
2018-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20180092468-A |
| titleOfInvention |
Composition for preventing and treating atherosclerosis or improving blood circulation comprising fermented fructus mume extract by bioconversion |
| abstract |
More particularly, the present invention relates to a composition for improving atherosclerosis or blood circulation using a biologically-transformed ocher fermentation extract. More particularly, the present invention relates to a composition for fermentation of ocher fermented by biosynthesis using Aspergillus sp. The present inventors have found that the inhibition of platelet aggregation and blood coagulation and antithrombotic effect can be achieved by inhibiting the migration of smooth muscle cells and the expression of angiogenic factors which cause platelet aggregation and blood coagulation, Can be provided as an effective therapeutic agent for arteriosclerosis and a hemostatic agent. |
| priorityDate |
2017-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |